Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Chronic Lymphocytic Leukemia

Welcome to the Cancer Connect Leukemia Resource Center and Community. Our goal is to bring patients, caregivers, advocates and experts together in a single community where individuals benefit from expert-authored news and educational programming alongside a robust social network.

  • Zydelig® Combinations Improve Survival in Recurrent CLL
    May 21, 2019

    Zydelig® Combinations Improve Survival in Recurrent CLL

    Dr. C H Weaver MD
  • Treatment of Chronic Lymphocytic Leukemia
    May 16, 2019

    Treatment of Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
  • Gazyva Combinations Represents Effective non Chemotherapy Option for Rx of CLL
    April 20, 2019

    Gazyva Combinations Represents Effective non Chemotherapy Option for Rx of CLL

    Dr. C H Weaver MD
  • Relapsed Chronic Lymphocytic Leukemia
    August 14, 2018

    Relapsed Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
  • Campath® + Rituxan has Significant Activity in Newly Diagnosed CLL
    January 12, 2018

    Campath® + Rituxan has Significant Activity in Newly Diagnosed CLL

    Dr. C H Weaver MD
  • Mini Transplants Provide Benefit in Patients w/ CLL Who Have Stopped to Fludara®
    October 5, 2009

    Mini Transplants Provide Benefit in Patients w/ CLL Who Have Stopped to Fludara®

    Dr. C H Weaver MD
  • Abnormal Cells Identified in Blood Years Before Diagnosis of CLL
    March 9, 2009

    Abnormal Cells Identified in Blood Years Before Diagnosis of CLL

    Dr. C H Weaver MD
  • Protein Expression Predicts Aggressiveness of Chronic Lymphocytic Leukemia
    March 8, 2009

    Protein Expression Predicts Aggressiveness of Chronic Lymphocytic Leukemia

    Dr. C H Weaver MD
  • Genetic Features Predict Response Chronic Lymphocytic Leukemia to Immunotherapy
    March 8, 2009

    Genetic Features Predict Response Chronic Lymphocytic Leukemia to Immunotherapy

    Dr. C H Weaver MD
  • Revlimid® Shows Promise as First-line Therapy of CLL
    March 8, 2009

    Revlimid® Shows Promise as First-line Therapy of CLL

    Dr. C H Weaver MD
  • FCR Treatment for CLL
    March 8, 2009

    FCR Treatment for CLL

    Dr. C H Weaver MD
Previous Page
1 2
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy
Loading Comments...